Atara Bio­ther­a­peu­tics to lay off 73 Cal­i­for­nia em­ploy­ees by the end of the year

Atara Bio­ther­a­peu­tics is lay­ing off 73 work­ers in Cal­i­for­nia at the end of the year, a lit­tle less than a month af­ter an­nounc­ing a re­struc­tur­ing and a failed Phase II tri­al in mul­ti­ple scle­ro­sis.

In No­vem­ber, Atara said it would be “un­der­tak­ing a strate­gic re­struc­tur­ing” and re­duc­ing its work­force by 30% and ex­pect­ed its cash to fund the com­pa­ny in­to the third quar­ter of 2025. The biotech al­so re­port­ed a net loss of $69.8 mil­lion, or $0.66 per share, for the third quar­ter this year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER